Ault Milton C III - Sep 26, 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Sep 26, 2025
Transactions value $
-$184,156
Form type
4
Date filed
9/30/2025, 07:15 PM
Previous filing
Sep 26, 2025
Next filing
Oct 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 2025-09-30 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale -$87.3K -37.7K -33.92% $2.31 73.5K Sep 26, 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Sale -$88.5K -38.3K -52.13% $2.31 35.2K Sep 29, 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Sale -$8.32K -3.57K -10.13% $2.33 31.6K Sep 30, 2025 By Ault Lending, LLC F1
holding ALZN Common Stock 1.84K Sep 26, 2025 Direct
holding ALZN Common Stock 11.1K Sep 26, 2025 By Ault Life Sciences, Inc. F2
holding ALZN Common Stock 61 Sep 26, 2025 By Ault Life Sciences Fund, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.